Mylan: Bad Earnings, Good News?

Shares of Mylan are rising even after the drug maker's third quarter financial results fell short of expectations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.